{"id":8557,"date":"2020-07-29T11:00:23","date_gmt":"2020-07-29T18:00:23","guid":{"rendered":"https:\/\/depts.washington.edu\/pandemicalliance\/?p=8557"},"modified":"2021-04-05T11:01:07","modified_gmt":"2021-04-05T18:01:07","slug":"baseline-cardiometabolic-profiles-and-sars-cov-2-risk-in-the-uk-biobank","status":"publish","type":"post","link":"https:\/\/depts.washington.edu\/pandemicalliance\/2020\/07\/29\/baseline-cardiometabolic-profiles-and-sars-cov-2-risk-in-the-uk-biobank\/","title":{"rendered":"Baseline Cardiometabolic Profiles and SARS-CoV-2 Risk in the UK Biobank"},"content":{"rendered":"<ul>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"34\" data-aria-posinset=\"2019\" data-aria-level=\"1\"><i><span data-contrast=\"none\">[pre-print, not peer-reviewed]<\/span><\/i><span data-contrast=\"auto\">\u00a0<\/span><span data-contrast=\"auto\">Scalsky\u00a0et al.\u00a0<\/span><span data-contrast=\"auto\">examined the effect of\u00a0<\/span><span data-contrast=\"auto\">c<\/span><span data-contrast=\"auto\">ardiometabolic\u00a0<\/span><span data-contrast=\"auto\">p<\/span><span data-contrast=\"auto\">rofiles\u00a0<\/span><span data-contrast=\"auto\">on the risk of testing positive for SARS-Co<\/span><span data-contrast=\"auto\">V<\/span><span data-contrast=\"auto\">-2 among 9,005 UK<\/span><span data-contrast=\"auto\">\u00a0<\/span><span data-contrast=\"auto\">B<\/span><span data-contrast=\"auto\">iobank<\/span><span data-contrast=\"auto\">\u00a0participants. They found that elevated\u00a0high density\u00a0lipoprotein (HDL) was associated with reduced risk of testing positive for SARS-CoV-2 (<\/span><span data-contrast=\"auto\">a<\/span><span data-contrast=\"auto\">OR=0.85). Type II diabetes and HbA1c were associated with increased risk (OR=1.21 and 1.06), but the effects\u00a0<\/span><span data-contrast=\"auto\">disappeared after<\/span><span data-contrast=\"auto\">\u00a0controlling for HDL.<\/span><span data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/li>\n<\/ul>\n<p><i><span data-contrast=\"none\">Scalsky\u00a0et al. (July 29, 2020). Baseline Cardiometabolic Profiles and SARS-CoV-2 Risk in the UK Biobank. Pre-print\u00a0downloaded July 29 from\u00a0<\/span><\/i><a href=\"https:\/\/doi.org\/10.1101\/2020.07.25.20161091\"><span data-contrast=\"none\">https:\/\/doi.org\/10.1101\/2020.07.25.20161091<\/span><\/a><span data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559685&quot;:720,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>[pre-print, not peer-reviewed]\u00a0Scalsky\u00a0et al.\u00a0examined the effect of\u00a0cardiometabolic\u00a0profiles\u00a0on the risk of testing positive for SARS-CoV-2 among 9,005 UK\u00a0Biobank\u00a0participants. They found that elevated\u00a0high density\u00a0lipoprotein (HDL) was associated with reduced risk of testing positive for SARS-CoV-2 (aOR=0.85). Type II diabetes and HbA1c were associated with increased risk (OR=1.21 and 1.06), but the effects\u00a0disappeared after\u00a0controlling for HDL.\u00a0 Scalsky\u00a0et al&#8230;.<\/p>\n<div><a class=\"more\" href=\"https:\/\/depts.washington.edu\/pandemicalliance\/2020\/07\/29\/baseline-cardiometabolic-profiles-and-sars-cov-2-risk-in-the-uk-biobank\/\">Read more<\/a><\/div>\n","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[6],"tags":[],"topic":[20],"class_list":["post-8557","post","type-post","status-publish","format-standard","hentry","category-article-summary","topic-clinical-characteristics-and-health-care-setting"],"_links":{"self":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/8557","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/comments?post=8557"}],"version-history":[{"count":1,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/8557\/revisions"}],"predecessor-version":[{"id":8558,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/8557\/revisions\/8558"}],"wp:attachment":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/media?parent=8557"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/categories?post=8557"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/tags?post=8557"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/topic?post=8557"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}